logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Hong Kong stock volatility | Junshi Biosciences (01877.HK) opens more than 11% higher, signed a authorization agreement with Fosun Pharma for toripalimab

date
02/07/2026
According to the Wisdom Financial APP, Junshi Biosciences (01877.HK) opened more than 11% higher, as of the time of publication, it has risen by 11.11%, trading at 18.5 Hong Kong dollars, with a trading volume of 1.6724 million Hong Kong dollars.
Latest
2 m ago
State Council Taiwan Affairs Office: The DPP authorities have become national scum and will inevitably face historical reckoning.
3 m ago
Hong Kong stocks rose | Zhongan Online (06060.HK) rose more than 5% during the trading session. The company increases investment in group health insurance innovation, and the industry is expected to see a key breakthrough in scale.
3 m ago
Deputy governor of the State Bank of Vietnam: Determined to keep inflation under control.
4 m ago
Merck: Animal Health's Sentinel will be launched in China.
4 m ago
Hong Kong stocks surged | Hengrui Medicine (01276.HK) rose more than 6% during the day. Recently, the innovative drug Erelie has added new indications, and the internationalization and overseas results have been quite fruitful.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.